V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004242 | 290003125 | 1.57 | 82.5 | null | 2014-02-24 | 2014-04-18 | ECF | N | null | 290020820 | GEMCARBO |
| 290004243 | 290003125 | 1.7 | 73.35 | Palliative (P) | 2015-12-26 | 2017-12-14 | Y-90 | 02 | N | 290020820 | CARBOPLATIN + PEMETREXED |
| 290004244 | 290003125 | 1.59 | 51 | Not known (9) | null | 2016-11-30 | CAPECITABINE + CARBOPLATIN | N | null | 290020820 | CISPLATIN + GEMCITABINE |
| 290004245 | 290003126 | 1.68 | 60.5 | Curative (C) | 2015-08-14 | 2015-09-17 | PACLITAXEL | N | Y | 290020826 | ABVD |
| 290004246 | 290003126 | 1.55 | 44.1 | null | 2017-06-23 | 2017-06-28 | CAP + RT | N | N | 290020826 | CARBOPLATIN + CETUXIMAB + FU |
| 290004247 | 290003127 | 1.54 | null | Palliative (P) | 2017-08-26 | 2017-09-02 | Capecitabine + Cisplatin | N | N | 290020833 | CETUXIMAB + RT |
| 290004248 | 290003128 | 1.76 | 96.5 | Neo-adjuvant (N) | 2013-12-02 | 2013-12-12 | Docetaxel 75mg/m2 (21 day) | N | N | 290020834 | CETUXIMAB |
| 290004249 | 290003129 | null | 117.7 | Neo-adjuvant (N) | 2016-12-11 | 2016-12-30 | Cetuximab 7 day (Cycle 1) | N | N | 290020835 | IVADO |
| 290004250 | 290003130 | null | 80 | Palliative (P) | 2017-07-13 | 2017-07-13 | Carboplatin+Fluorouracil 4 or 5 day | N | null | 290020837 | GEMCARBO |
| 290004251 | 290003131 | 1.5 | null | Disease modification (D) | null | 2013-09-22 | CARBOPLATIN | N | N | 290020838 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004252 | 290003132 | 1.75 | 83.5 | null | 2017-02-27 | 2017-02-27 | Capecitabine | N | N | 290020839 | CETUXIMAB + CISPLATIN + FU |
| 290004253 | 290003133 | 1.68 | 51.3 | Neo-adjuvant (N) | 2017-07-10 | 2017-07-11 | Capecitabine | 01 | N | 290020840 | CAPECITABINE + CISPLATIN |
| 290004254 | 290006447 | 1.72 | 0 | Palliative (P) | 2014-02-25 | 2014-03-28 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 290020842 | LANREOTIDE |
| 290004255 | 290003134 | 1.77 | 68.4 | Neo-adjuvant (N) | 2017-11-29 | 2017-12-04 | Capecitabine 35days + RT | N | N | 290020843 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 290004256 | 290003135 | 1.67 | null | Adjuvant (A) | 2013-04-01 | 2013-04-23 | CISPLATIN + FLUOROURACIL | N | N | 290020847 | CAPECITABINE |
| 290004257 | 290003135 | 1.69 | 101 | Disease modification (D) | null | 2016-05-15 | Cisplatin +Fluorouracil (3 wk) | N | N | 290020847 | CAPECITABINE |
| 290004258 | 290003136 | 1.77 | 82.5 | Palliative (P) | 2017-12-10 | 2017-12-10 | OCTREOTIDE | 02 | N | 290020853 | CISPLATIN + FLUOROURACIL |
| 290004259 | 290003137 | 1.56 | 94.2 | Curative (C) | 2016-08-16 | 2016-08-17 | FLUOROURACIL + IRINOTECAN | N | Y | 290020855 | CAPECITABINE |
| 290004260 | 290003138 | 1.64 | null | Curative (C) | 2014-01-12 | 2014-01-21 | Capecitabine + Cisplatin | null | N | 290020856 | CAPECITABINE + STREPTOZOCIN |
| 290004261 | 290006449 | 1.8 | 65.9 | Palliative (P) | 2016-12-19 | 2016-12-19 | Irinotecan + Modified De Gramont | N | N | 290020857 | CARBOPLATIN + ETOPOSIDE |
| 290004262 | 290003139 | null | 70.4 | null | 2015-07-21 | 2015-07-27 | Fluorouracil + Folinic Acid Weekly | N | N | 290020859 | CAPECITABINE + RT |
| 290004263 | 290006450 | null | null | Disease modification (D) | 2017-07-15 | 2017-07-18 | FOXFIRE TRIAL | N | N | 290020861 | EOX |
| 290004264 | 290006450 | null | 62.9 | Palliative (P) | 2016-12-02 | 2016-12-02 | CETUXIMAB + RT | 02 | N | 290020861 | CAPECITABINE + RT |
| 290004265 | 290006450 | 1.71 | 87.1 | Neo-adjuvant (N) | 2014-11-25 | 2014-12-03 | OCTREOTIDE | N | N | 290020861 | TRIAL |
| 290004266 | 290003140 | 1.66 | 0 | Neo-adjuvant (N) | 2013-10-11 | 2013-10-11 | EOX | 02 | N | 290020868 | PACLITAXEL |
| 290004267 | 290003141 | 1.65 | 53 | Palliative (P) | 2014-04-01 | 2014-04-08 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 290020874 | CARBOPLATIN + ETOPOSIDE |
| 290004268 | 290003141 | 0 | 61.9 | Palliative (P) | 2014-03-06 | 2014-03-07 | CARBOPLATIN + PACLITAXEL | 2 | N | 290020874 | TRIAL |
| 290004269 | 290003141 | 1.74 | 52.6 | Neo-adjuvant (N) | 2015-10-25 | 2015-11-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290020874 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290004270 | 290003142 | 1.62 | 49.6 | Palliative (P) | 2016-12-28 | 2016-12-28 | CARBOPLATIN + FLUOROURACIL | 02 | null | 290020881 | CARBOPLATIN + CETUXIMAB |
| 290004271 | 290003143 | 1.64 | 70 | Adjuvant (A) | 2015-10-03 | 2015-10-03 | Trial Unspecified | 02 | N | 290020884 | OCTREOTIDE |
| 290004272 | 290003144 | 1.76 | 56.2 | Adjuvant (A) | 2014-02-25 | 2014-03-05 | Cisplatin + Docetaxel +Fluorouracil | null | N | 290020885 | ECX |
| 290004273 | 290006452 | 1.58 | 102 | Disease modification (D) | 2015-03-07 | 2015-03-07 | CHOP R - 21 days | 2 | N | 290020888 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004274 | 290003145 | 1.73 | null | Not known (9) | 2016-11-29 | 2016-12-19 | BALLAD Trial | 02 | Y | 290020889 | CHLORAMBUCIL + RITUXIMAB |
| 290004275 | 290003146 | 1.61 | 81 | Adjuvant (A) | 2017-02-26 | 2017-03-19 | Cetuximab 7 day (Cycle 1) | N | Y | 290020890 | CAPECITABINE |
| 290004276 | 290003147 | null | 0 | Neo-adjuvant (N) | 2013-08-11 | 2013-09-07 | GEMCITABINE | N | Y | 290020891 | CAPECITABINE + RT |
| 290004277 | 290003148 | 1.66 | 99.9 | Adjuvant (A) | 2016-07-24 | 2017-04-02 | Paclitaxel 7 day | 02 | N | 290020894 | CISPLATIN + FLUOROURACIL |
| 290004278 | 290003149 | 1.58 | null | Palliative (P) | 2013-04-19 | 2013-04-19 | GEMCITABINE | N | N | 290020895 | LU-177 |
| 290004279 | 290006453 | 1.68 | 66.2 | Disease modification (D) | 2017-01-20 | 2017-01-20 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290020899 | CISPLATIN + FLUOROURACIL |
| 290004280 | 290006453 | 1.7 | 121.6 | Adjuvant (A) | 2016-04-07 | 2016-04-07 | ICON8 TRIAL | 02 | N | 290020899 | CISPLATIN + FLUOROURACIL |
| 290004281 | 290003150 | null | null | Adjuvant (A) | 2016-07-18 | 2016-09-08 | Cisplatin + Fluorouracil + RT 5day | N | N | 290020901 | FLUOROURACIL |
| 290004282 | 290006454 | 1.58 | 48 | null | 2013-02-19 | 2013-03-03 | Fluorouracil 96hr infusion+R(4g/m2) | 02 | null | 290020903 | CAPECITABINE + RT |
| 290004283 | 290006454 | null | 48.3 | Palliative (P) | 2015-08-05 | 2015-08-05 | CTD | 02 | N | 290020903 | CARBOPLATIN + PACLITAXEL |
| 290004284 | 290003151 | 1.85 | 67.7 | null | 2018-06-08 | 2018-06-08 | Capecitabine | N | N | 290020907 | IRINOTECAN + MDG |
| 290004285 | 290003152 | 1.7 | 71 | Curative (C) | 2013-05-18 | 2013-05-23 | CVD (Neuroendocrine) | 2 | Y | 290020909 | BALLAD TRIAL |
| 290004286 | 290003152 | 154 | 144.7 | Palliative (P) | 2016-10-31 | 2016-11-14 | Irinotecan + Modified De Gramont | 02 | N | 290020909 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004287 | 290003153 | 1.75 | 96.5 | null | 2017-09-28 | 2017-10-18 | CARBOPLATIN + RT | 02 | N | 290020911 | CISPLATIN + ETOPOSIDE |
| 290004288 | 290003154 | 1.63 | 67 | Palliative (P) | 2017-08-29 | 2017-09-18 | Fluorouricil + Folonic Acid (MdG) | N | N | 290020914 | CAPECITABINE |
| 290004289 | 290003154 | null | 79.5 | Adjuvant (A) | 2013-09-02 | 2013-09-04 | LANREOTIDE | 02 | null | 290020914 | LANREOTIDE |
| 290004290 | 290003155 | 1.56 | 87.5 | Palliative (P) | 2013-04-27 | 2013-05-19 | Carboplatin + Etoposide IV 3 day | 02 | N | 290020918 | EOX |
| 290004291 | 290003155 | 1.64 | 61.4 | Neo-adjuvant (N) | null | 2016-03-06 | CAPECITABINE + RT | N | N | 290020918 | CISPLATIN + ETOPOSIDE |